Product information

Current status:

Cancelled Pre Market

Current status date:

2017-09-12

Original market date: ^{See footnote 1}

Product name:

BRIMONIDINE OPHTHALMIC

DIN:

02246283 Electronic product monograph is not available

Company:

PHARMEL INC
6111, Avenue Royalmount, Suite 100
Montreal
Quebec
Canada H4P 2T4

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Ophthalmic

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

52:40.04 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

S01EA05 BRIMONIDINE

Active ingredient group (AIG) number:^{See footnote5}

0131859001